摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-hydroxy-2-{1-isopropyl-3-[({4-{(2-methyl-4-quinolinyl)methoxy]phenyl}sulfonyl)methyl]-3-pyrrolidinyl}acetamide

中文名称
——
中文别名
——
英文名称
N-hydroxy-2-{1-isopropyl-3-[({4-{(2-methyl-4-quinolinyl)methoxy]phenyl}sulfonyl)methyl]-3-pyrrolidinyl}acetamide
英文别名
N-Hydroxy-2-{1-isopropyl-3-[4-(2-methyl-quinolin-4-ylmethoxy)-benzenesulfonylmethyl]-pyrrolidin-3-yl}-acetamide;N-hydroxy-2-[3-[[4-[(2-methylquinolin-4-yl)methoxy]phenyl]sulfonylmethyl]-1-propan-2-ylpyrrolidin-3-yl]acetamide
N-hydroxy-2-{1-isopropyl-3-[({4-{(2-methyl-4-quinolinyl)methoxy]phenyl}sulfonyl)methyl]-3-pyrrolidinyl}acetamide化学式
CAS
——
化学式
C27H33N3O5S
mdl
——
分子量
511.642
InChiKey
AENHIDVKFOYIJJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    117
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • 1,1-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha
    申请人:——
    公开号:US20020137734A1
    公开(公告)日:2002-09-26
    The present application describes novel 1,1-disubsituted cyclic derivatives of formula I: 1 or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-8 membered non-aromatic ring consisting of: carbon atoms, 0-1 carbonyl groups, 0-1 double bonds, and from 0-2 ring heteroatoms selected from O, N, NR 2 , S, S(O), and S(O) 2 and the other variables are defined in the present specification, which are useful as metalloprotease and as TNF-&agr; inhibitors.
    本申请描述了新型的1,1-二取代环状衍生物的公式I:1或其药学上可接受的盐形式,其中环B是由碳原子、0-1个羰基基团、0-1个双键和0-2个从O、N、NR2、S、S(O)和S(O)2中选择的环异原子组成的3-8环非芳香环,其他变量在本说明书中定义,这些衍生物可用作金属蛋白酶和TNF-α抑制剂。
  • US6825215B2
    申请人:——
    公开号:US6825215B2
    公开(公告)日:2004-11-30
  • Synthesis and structure–activity relationship of a novel sulfone series of TNF-α converting enzyme inhibitors
    作者:Chu-Biao Xue、Xiao-Tao Chen、Xiaohua He、John Roderick、Ronald L. Corbett、Bahman Ghavimi、Rui-Qin Liu、Maryanne B. Covington、Mingxin Qian、Maria D. Ribadeneira、Krishna Vaddi、James Trzaskos、Robert C. Newton、James J.-W. Duan、Carl P. Decicco
    DOI:10.1016/j.bmcl.2004.06.049
    日期:2004.9
    Replacement of the amide functionality in IM491 (N-hydroxy-(5S,6S)-1-methyl-6-[4-(2-methyl-4-quinolinylmethoxy)anilinyl]carbonyl}-5-piperidinecarboxamide) with a sulfonyl group led to a new series of alpha,beta-cyclic and beta,beta-cyclic gamma-sulfonyl hydroxamic acids, which were potent TNF-alpha converting enzyme (TACE) inhibitors. Among them, inhibitor 4b (N-hydroxy(4S,5S)-1-methyl-5-1[4-(2-methyl-4-quinolinylmethoxy)phenyl]sulfonylmethyl -4-pyrrolidinecarboxamide) exhibited IC50 values of <1 nM and 180 nM in porcine TACE (pTACE) and cell assays, respectively, with excellent selectivity over MMP- 1, -2, -9 and - 13 and was orally bioavailable with an F value of 46% in mice. (C) 2004 Published by Elsevier Ltd.
查看更多